Literature DB >> 16492150

Cellular analysis of disorazole C and structure-activity relationship of analogs of the natural product.

Peter Wipf1, Thomas H Graham, Andreas Vogt, Rachel P Sikorski, Alexander P Ducruet, John S Lazo.   

Abstract

Structure-activity analyses of synthetic disorazole C(1) and eight of its analogs indicate that the presence of a vinyl oxirane moiety or a tetraene sequence is not necessary for potent cytotoxic and antimitotic properties. Using an automated multiparameter fluorescence-based cellular assay to simultaneously probe the effects of disorazole analogs on cellular microtubules, mitotic arrest, and cytotoxicity, we found that disorazole C(1) enhanced the mitotic index and chromatin condensation and arrested cells in the G2/M phase of the cell cycle. All structural analogs and synthesis precursors of disorazole C(1) were at least two orders of magnitude less potent than the parent compound, thus indicating that both the functional group array and the three-dimensional conformation of the parent compound are critical for interaction with the biological target. We conclude that disorazole C(1) is a potent inducer of mitotic arrest and hypothesize that this biological activity may be mediated by microtubule perturbation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16492150     DOI: 10.1111/j.1747-0285.2005.00313.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  11 in total

1.  Total synthesis of (-)-CP2-disorazole C1.

Authors:  Chad D Hopkins; John C Schmitz; Edward Chu; Peter Wipf
Journal:  Org Lett       Date:  2011-07-08       Impact factor: 6.005

2.  Identifying a resistance determinant for the antimitotic natural products disorazole C1 and A1.

Authors:  John S Lazo; Celeste E Reese; Andreas Vogt; Laura L Vollmer; Carolyn A Kitchens; Eckhard Günther; Thomas H Graham; Chad D Hopkins; Peter Wipf
Journal:  J Pharmacol Exp Ther       Date:  2009-12-15       Impact factor: 4.030

3.  Mitotic slippage in non-cancer cells induced by a microtubule disruptor, disorazole C1.

Authors:  Fengfeng L Xu; Youssef Rbaibi; Kirill Kiselyov; John S Lazo; Peter Wipf; William S Saunders
Journal:  BMC Chem Biol       Date:  2010-02-11

4.  High-content analysis of cancer-cell-specific apoptosis and inhibition of in vivo angiogenesis by synthetic (-)-pironetin and analogs.

Authors:  Andreas Vogt; Peter A McPherson; Xiaoqiang Shen; Raghavan Balachandran; Guangyu Zhu; Brianne S Raccor; Scott G Nelson; Michael Tsang; Billy W Day
Journal:  Chem Biol Drug Des       Date:  2009-08-18       Impact factor: 2.817

Review 5.  Isolation, biology and chemistry of the disorazoles: new anti-cancer macrodiolides.

Authors:  Chad D Hopkins; Peter Wipf
Journal:  Nat Prod Rep       Date:  2009-03-11       Impact factor: 13.423

6.  Meayamycin inhibits pre-messenger RNA splicing and exhibits picomolar activity against multidrug-resistant cells.

Authors:  Brian J Albert; Peter A McPherson; Kristine O'Brien; Nancy L Czaicki; Vincent Destefino; Sami Osman; Miaosheng Li; Billy W Day; Paula J Grabowski; Melissa J Moore; Andreas Vogt; Kazunori Koide
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261

7.  Microtubule binding and disruption and induction of premature senescence by disorazole C(1).

Authors:  Marni Brisson Tierno; Carolyn A Kitchens; Bethany Petrik; Thomas H Graham; Peter Wipf; Fengfeng L Xu; William S Saunders; Brianne S Raccor; Raghavan Balachandran; Billy W Day; Jane R Stout; Claire E Walczak; Alexander P Ducruet; Celeste E Reese; John S Lazo
Journal:  J Pharmacol Exp Ther       Date:  2008-12-09       Impact factor: 4.030

8.  Synthesis and biological evaluation of (-)-dictyostatin and stereoisomers.

Authors:  Youseung Shin; Jean-Hugues Fournier; Arndt Brückner; Charitha Madiraju; Raghavan Balachandran; Brianne S Raccor; Michael C Edler; Ernest Hamel; Rachel P Sikorski; Andreas Vogt; Billy W Day; Dennis P Curran
Journal:  Tetrahedron       Date:  2007-08-27       Impact factor: 2.457

9.  Self-Assembly of Disorazole C1 through a One-Pot Alkyne Metathesis Homodimerization Strategy.

Authors:  Kevin J Ralston; H Clinton Ramstadius; Richard C Brewster; Helen S Niblock; Alison N Hulme
Journal:  Angew Chem Int Ed Engl       Date:  2015-04-29       Impact factor: 15.336

10.  Bis-cyclopropane analog of disorazole C1 is a microtubule-destabilizing agent active in ABCB1-overexpressing human colon cancer cells.

Authors:  Shaoyu Wu; Zhijian Guo; Chad D Hopkins; Ning Wei; Edward Chu; Peter Wipf; John C Schmitz
Journal:  Oncotarget       Date:  2015-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.